Search results
Results from the WOW.Com Content Network
It generally affects about 10–40% of breast cancer patients, with higher rates among pre-menopausal women and patients who receive high-dose chemotherapy. Additionally, there are high complaints of cognitive impairment in glioblastoma patients, 60-85% of patients report cancer-related cognitive impairments following surgery and adjunctive ...
Radiation-induced cognitive decline describes the possible correlation between radiation therapy and cognitive impairment. Radiation therapy is used mainly in the treatment of cancer. Radiation therapy can be used to cure, care or shrink tumors that are interfering with quality of life. Sometimes radiation therapy is used alone; other times it ...
Chemoreceptor. A chemoreceptor, also known as chemosensor, is a specialized sensory receptor which transduces a chemical substance ( endogenous or induced) to generate a biological signal. [ 1] This signal may be in the form of an action potential, if the chemoreceptor is a neuron, [ 2] or in the form of a neurotransmitter that can activate a ...
Low-dose chemotherapy is being studied/used in the treatment of cancer to avoid the side effects of conventional chemotherapy. Historically, oncologists have used the highest possible dose that the body can tolerate in order to kill as many cancer cells as possible. [1] After high-dose treatments, the body reacts, sometimes quite severely.
The economic stress Seabrook children face is borne out by the district’s very high number – 80 percent – of children whose parents’ income levels qualify annually for the free and reduced ...
Acute radiation syndrome. Radiation causes cellular degradation by autophagy. Acute radiation syndrome ( ARS ), also known as radiation sickness or radiation poisoning, is a collection of health effects that are caused by being exposed to high amounts of ionizing radiation in a short period of time. [ 1] Symptoms can start within an hour of ...
For premium support please call: 800-290-4726 more ways to reach us
Chemotherapy-induced peripheral neuropathy (CIPN) is a nerve -damaging side effect of antineoplastic agents in the common cancer treatment, chemotherapy. [1] CIPN afflicts between 30% and 40% of patients undergoing chemotherapy. Antineoplastic agents in chemotherapy are designed to eliminate rapidly dividing cancer cells, but they can also ...